Modeling the Evolution of Ploidy in a Resource Restricted Environment

  • Gregory Kimmel
  • Jill Barnholtz-Sloan
  • Hanlee Ji
  • Philipp Altrock
  • Noemi AndorEmail author
Conference paper
Part of the Lecture Notes in Computer Science book series (LNCS, volume 11826)


Gliomas are tumors that evolve from glial cells in the brain or spine. Most gliomas are diagnosed as either lower-grade lesions (grade II) or Glioblastoma (grade IV). Progression of lower-grade gliomas (LGG) to Glioblastoma (GBM) is accompanied by a phenotypic switch to a highly invasive tumor cell phenotype. Converging evidence from different cancer types, including colorectal-, breast-, and lung- cancers, suggests a strong enrichment of high ploidy cells among metastatic lesions as compared to the primary tumor [1, 2]. Even in normal development: trophoblast giant cells - the first cell type to terminally differentiate during embryogenesis - are responsible for invading the placenta and strikingly these cells can have up to 1000 copies of the genome [5]. All this points to the existence of a ubiquitous mechanism that links high DNA content to an invasive phenotype. We formulate a mechanistic Grow-or-go model that postulates higher energy demands of high-ploidy cells as a driver of their invasive behavior. We will test whether this mechanism may contribute to the quick recurrence of GBMs after surgery [7] and whether it can explain striking differences in the prognostic power of integrin signaling and cell cycle progression between males and females [13].


Ploidy Glioblastoma Mathematical modeling 


  1. 1.
    Angelova, M., et al.: Evolution of metastases in space and time under immune selection. Cell 175(3), 751–765.e16 (2018). ISSN: 0092-8674, Accessed 15 Mar 2019CrossRefGoogle Scholar
  2. 2.
    Brastianos, P.K., et al.: Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets. Cancer Discovery 5(11), 1164–1177 (2015). ISSN: 2159-8290CrossRefGoogle Scholar
  3. 3.
    Chen, G., et al.: Hsp90 stress potentiates rapid cellular adaptation through induction of aneuploidy. Nature 482(7384), 246–250 (2012). ISSN: 1476-4687CrossRefGoogle Scholar
  4. 4.
    Chen, G., et al.: Targeting the adaptability of heterogeneous aneuploids. Cell 160(4), 771–784 (2015). ISSN: 1097-4172CrossRefGoogle Scholar
  5. 5.
    Hannibal, R.L., et al.: Copy number variation is a fundamental aspect of the placental genome. PLoS Genet. 10(5), e1004290 (2014). ISSN: 1553-7404CrossRefGoogle Scholar
  6. 6.
    Hastings, P.J., et al.: Mechanisms of change in gene copy number. Nat. Rev. Genet. 10(8), 551–564 (2009). ISSN: 1471-0056, Accessed 15 Aug 2015CrossRefGoogle Scholar
  7. 7.
    Hatzikirou, H., et al.: ‘Go or grow’: the key to the emergence of invasion in tumour progression? Math. Med. Biol. J. IMA 29(1), 49–65 (2012). ISSN:1477-8602MathSciNetCrossRefzbMATHGoogle Scholar
  8. 8.
    Mroz, E.A., et al.: Intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas. PLoS Med. 12(2), e1001786 (2015). ISSN: 1549-1676CrossRefGoogle Scholar
  9. 9.
    Puchalski, R.B., et al.: An anatomic transcriptional atlas of human glioblastoma. Science 360(6389), 660–663 (2018). ISSN: 0036-8075, 1095-9203, Accessed 15 Mar 2019CrossRefGoogle Scholar
  10. 10.
    Saut, O., et al.: A multilayer grow-or-go model for GBM: effects of invasive cells and anti-angiogenesis on growth. Bull. Math. Biol. 76(9), 2306–2333 (2014). ISSN: 1522-9602MathSciNetCrossRefzbMATHGoogle Scholar
  11. 11.
    Soukup, S.W., Ohno, S.: Evolution by Gene Duplication, p. 160. Springer, New York (1970). Teratology 9(2), 250–251 (1974). ISSN: 1096-9926,, Accessed 31 Aug 2014CrossRefGoogle Scholar
  12. 12.
    Worrall, J.T., et al.: Non-random mis-segregation of human chromosomes. Cell Rep. 23(11), 3366–3380 (2018). ISSN: 2211-1247CrossRefGoogle Scholar
  13. 13.
    Yang, W., et al.: Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data. Sci. Trans. Med. 11(473), eaao5253 (2019). ISSN: 1946-6234, 1946-6242, Accessed 15 Mar 2019CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Gregory Kimmel
    • 1
  • Jill Barnholtz-Sloan
    • 3
  • Hanlee Ji
    • 2
  • Philipp Altrock
    • 1
  • Noemi Andor
    • 1
    Email author
  1. 1.Integrated Mathematical OncologyMoffitt Cancer CenterTampaUSA
  2. 2.School of MedicineStanford UniversityStanfordUSA
  3. 3.Case Comprehensive Cancer Center, Cleveland Institute for Computational BiologyCase Western Reserve University School of MedicineClevelandUSA

Personalised recommendations